SCHEMBL291318

SCHEMBL291318

CC1CCC(C(C)C)C(C(=O)Nc2ccc(C(N)=O)cc2)C1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 5/20 0.70
EPHX1 P07099 1/20 0.54
TRPV1 Q8NER1 2/20 0.45
HPGD P15428 2/20 0.45
CYP2C9 P11712 1/20 0.45
NPC1 O15118 3/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
HSD17B10 Q99714 1/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628645 1.00 TRPM8 (0.70) TRPM8EPHX1TRPV1HPGDCYP2C9
SCHEMBL2628616 0.89 TRPM8 (0.72) TRPM8EPHX1TRPV1NPC1ALDH1A1
SCHEMBL4886771 0.89 TRPM8 (0.72) TRPM8EPHX1TRPV1HPGDNPC1
SCHEMBL369792 0.89 TRPM8 (0.72) TRPM8EPHX1TRPV1NPC1ALDH1A1
SCHEMBL13989013 0.86 TRPM8 (0.76) TRPM8EPHX1TRPV1HPGDNPC1
SCHEMBL299356 0.86 TRPM8 (0.58) TRPM8EPHX1TRPV1ALDH1A1MEN1
SCHEMBL2628779 0.86 TRPM8 (0.58) TRPM8EPHX1TRPV1ALDH1A1MEN1
SCHEMBL4817319 0.86 TRPM8 (0.75) TRPM8EPHX1TRPV1HPGDNPC1
SCHEMBL10073486 0.86 TRPM8 (0.75) TRPM8EPHX1TRPV1HPGDNPC1
SCHEMBL2628672 0.86 TRPM8 (0.75) TRPM8EPHX1TRPV1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US claimed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US claimed
US-20120095042-A1 Organic Compounds Having Cooling Properties GIVAUDAN SA (CH) 2012-04-19 US claimed
EP-2427170-A2 ORGANIC COMPOUNDS HAVING COOLING PROPERTIES Givaudan SA (CH) 2012-03-14 EP claimed
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties GIVAUDAN SA (CH) 2011-07-28 US claimed
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US claimed
EP-2250154-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS Givaudan SA (CH) 2010-11-17 EP claimed
WO-2010128026-A2 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2010-11-11 WO claimed
EP-2229352-A2 CARBOXAMIDE DERIVATIVES HAVING COOLING PROPERTIES Givaudan SA (CH) 2010-09-22 EP claimed
WO-2009089641-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS COOLING AGENTS GIVAUDAN SA (CH) 2009-07-23 WO claimed
WO-2009070910-A2 CARBOXAMIDE DERIVATIEVES HAVING COOLING PROPERTIES GIVAUDAN SA (CH) 2009-06-11 WO claimed
EP-2296759-B1 COOLING COMPOSITION GIVAUDAN SA (CH) 2019-10-02 EP disclosed
CN-102036716-B Cooling composition GIVAUDAN S.A. (CH) 2016-02-10 CN disclosed
US-8664261-B2 Organic compounds having cooling properties GIVAUDAN S.A. (CH) 2014-03-04 US disclosed
US-8377422-B2 Carboxamide derivatives having cooling properties GIVAUDAN S.A. (CH) 2013-02-19 US disclosed
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents GIVAUDAN S.A. (CH) 2010-11-25 US disclosed
US-20100292294-A1 Compositions Comprising a Physiological Coolant GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2010-11-18 US disclosed
EP-2134319-A2 COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT Givaudan Nederland Services B.V. (NL) 2009-12-23 EP disclosed
WO-2009140783-A1 COOLING COMPOSITION GIVAUDAN SA (CH) 2009-11-26 WO disclosed
WO-2008107137-A2 COMPOSITIONS COMPRISING A PHYSIOLOGICAL COOLANT GIVAUDAN NEDERLAND SERVICES B.V. (NL) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297038-A1 Benzimidazole Derivatives And Their Use As Cooling Agents OR10J3, H1-3, ORC3 TRPM8 2049/4885EPHX1 2518/4885TRPV1 1623/4885
US-20110182833-A1 Carboxamide Derivatives Having Cooling Properties CPS1, NQO2, NDUFA2 TRPM8 376/4885EPHX1 3112/4885TRPV1 161/4885
US-20120095042-A1 Organic Compounds Having Cooling Properties ME3, ME2, MSMO1 TRPM8 361/4885EPHX1 1320/4885TRPV1 945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.